COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease (REBUILD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04189315
Recruitment Status : Withdrawn (R&D portfolio review and in light of the global impact of the COVID-19 pandemic)
First Posted : December 6, 2019
Last Update Posted : June 4, 2020
Information provided by (Responsible Party):
Alexion Pharmaceuticals

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2022